Ajouter à une liste

Instrument Inactif

Autres langues CURE PHAR Other OTC

Actions

US56088C1009

Cours en clôture Other OTC
- ^USD	-

Autres langues

07/06/17	Leading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing Market
31/05/17	CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids
24/05/17	CURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.
18/05/17	CURE Pharmaceutical Announces Crosslink Patent for Covering Company’s Proprietary CureFilm™ Drug Delivery Technology
10/05/17	CURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis Industry
09/05/17	CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
03/05/17	CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors
29/03/17	CURE Pharmaceutical Announces Development and Licensing Deal with Redbarn Pet Products
27/03/17	CURE Pharmaceutical To Exhibit at the 8th Global Drug Delivery & Formulation Summit
23/03/17	CURE Pharmaceutical Welcomes Researcher and Innovator in Pediatric Medicine Michael Neely to Advisory Board
21/03/17	CURE Pharmaceutical Announces Product Development and Licensing Deal with Diverse International Pharmaceutical Company Meroven, Ltd.
16/03/17	CURE Pharmaceutical To Exhibit at INTERPHEX 2017 in New York City
15/03/17	Industry Veteran Jessica Rousset Joins CURE Pharmaceutical As Chief Business Officer
13/03/17	CURE Pharmaceutical Announces US Patent Allowances for Its Oral Thin Film Technology For Manufacture and Use in Pet Products
06/03/17	CURE Pharmaceutical Announces Research Collaboration with CannaKids to Develop Cannabinoid and Terpene Molecules Using Cure’s Proprietary Delivery Technologies
27/01/17	CURE Pharmaceutical Welcomes Industry Veteran Richard Serbin to its Advisory Board
24/01/17	CURE Pharmaceutical Moves to OTCQB Exchange

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !

PROFITEZ-EN MAINTENANT